Sign In
Buy CAI
$15.67
-0.420 (-2.61%)
At Close: Jul 31, 2026
Cancer Test Maker Caris Life Sciences Unveils Breakthrough In Early Cancer Detection, Profit Surprise
07:00am, Friday, 27'th Feb 2026
Caris Life Sciences Inc. (NASDAQ: CAI) shares are up during Friday's premarket session following better-than-expected fourth-quarter earnings and a significant interim readout from the company's Achie
Caris Life Sciences Completes Interim Readout of Achieve 1 Study
06:00pm, Thursday, 26'th Feb 2026
Demonstrates Superior Sensitivity and Specificity of Caris Detect Results demonstrate the superiority of Whole Genome Sequencing compared to methylation-based approaches IRVING, Texas, Feb. 26, 2026
Caris Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook
04:05pm, Thursday, 26'th Feb 2026
Full year revenue growth of 97% driven by strong performance in molecular profiling services Expects full year 2026 revenue to be in the range of $1.0 billion to $1.02 billion IRVING, Texas, Feb. 26,
IRVING, Texas, Feb. 24, 2026 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced a ne
Caris Life Sciences to Participate in the TD Cowen 46th Annual Health Care Conference
08:30am, Monday, 23'rd Feb 2026
IRVING, Texas, Feb. 23, 2026 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced tha
Caris Life Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26
08:30am, Monday, 09'th Feb 2026
IRVING, Texas, Feb. 9, 2026 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced it wil
Billiontoone (NASDAQ:BLLN) & Caris Life Sciences (NASDAQ:CAI) Head to Head Review
01:26am, Monday, 02'nd Feb 2026
Billiontoone (NASDAQ: BLLN - Get Free Report) and Caris Life Sciences (NASDAQ: CAI - Get Free Report) are both mid-cap services companies, but which is the better stock? We will compare the two compan
Billiontoone (NASDAQ:BLLN) vs. Caris Life Sciences (NASDAQ:CAI) Critical Contrast
01:10am, Sunday, 01'st Feb 2026
Caris Life Sciences (NASDAQ: CAI - Get Free Report) and Billiontoone (NASDAQ: BLLN - Get Free Report) are both mid-cap services companies, but which is the better business? We will contrast the two bu
Caris Life Sciences' Real-World Data Uncovers Metastatic Breast Cancer Patient Responses and Resistance to Trastuzumab Deruxtecan
08:30am, Wednesday, 28'th Jan 2026
IRVING, Texas, Jan. 28, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, has published a study i
Critical Contrast: Caris Life Sciences (NASDAQ:CAI) & Billiontoone (NASDAQ:BLLN)
01:00am, Monday, 26'th Jan 2026
Caris Life Sciences (NASDAQ: CAI - Get Free Report) and Billiontoone (NASDAQ: BLLN - Get Free Report) are both mid-cap services companies, but which is the better business? We will contrast the two bu
Caris Life Sciences, Inc. (CAI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
06:55pm, Monday, 12'th Jan 2026
Caris Life Sciences, Inc. (CAI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results
08:30am, Monday, 12'th Jan 2026
Full year revenue growth of approximately 94% driven by strong performance in molecular profiling services IRVING, Texas, Jan. 12, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leadin
Caris Life Sciences Partners with Everlywell to Launch Caris' Forthcoming MCED Assay, Caris Detect
08:00am, Monday, 12'th Jan 2026
IRVING, Texas, Jan. 12, 2026 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced a pa
Caris Life Sciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
08:30am, Monday, 05'th Jan 2026
IRVING, Texas, Jan. 5, 2026 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced that
The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute
08:30am, Friday, 19'th Dec 2025
IRVING, Texas , Dec. 19, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced that
